Literature DB >> 1549229

Fatal meningoencephalitis caused by reactivation of Trypanosoma cruzi infection in a patient with AIDS.

S Rosemberg1, C J Chaves, M L Higuchi, M B Lopes, L H Castro, L R Machado.   

Abstract

We report a case of fatal chagasic meningoencephalitis in an AIDS patient. Acute exacerbation of chronic Chagas' disease with involvement of the CNS is uncommon and occurs only in immunocompromised patients. This is the third such reported reactivation and it underscores the importance of considering Chagas' disease in HIV-positive patients from endemic regions.

Entities:  

Mesh：

Year:  1992        PMID： 1549229     DOI： 10.1212/wnl.42.3.640

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  15 in total

1.  Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Authors:  Swinburne A J Augustine; Yuliya Y Kleshchenko; Pius N Nde; Siddharth Pratap; Edward A Ager; James M Burns; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection.

Authors:  Pius N Nde; Kaneatra J Simmons; Yuliya Y Kleshchenko; Siddharth Pratap; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

3.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

4.  Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease.

Authors:  R L Tarleton; J Sun; L Zhang; M Postan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.

Authors:  Pius N Nde; Candice A Johnson; Siddharth Pratap; Tatiana C Cardenas; Yuliya Y Kleshchenko; Vyacheslav A Furtak; Kaneatra J Simmons; Maria F Lima; Fernando Villalta
Journal:  Chem Biodivers       Date:  2010-05       Impact factor: 2.408

6.  Trypanosoma cruzi promotes neuronal and glial cell survival through the neurotrophic receptor TrkC.

Authors:  Craig Weinkauf; Mercio Pereiraperrin
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

7.  Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Susana A Laucella; María Gabriela Alvarez; Esteban Rodrigo Fernandez; Bruno Lococo; Rodolfo Viotti; Rick L Tarleton; Miriam Postan
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

Review 8.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

9.  The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide.

Authors:  F Villalta; Y Zhang; K E Bibb; J C Kappes; M F Lima
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Human autoantibodies specific for neurotrophin receptors TrkA, TrkB, and TrkC protect against lethal Trypanosoma cruzi infection in mice.

Authors:  Bo Lu; Joseph Alroy; Alejandro O Luquetti; Mercio PereiraPerrin
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.